Molecular Mechanisms and Targets of Therapy for Hepatocellular Carcinoma

被引:41
作者
Klungboonkrong, Vivian [1 ,4 ]
Das, Dola [2 ,3 ]
McLennan, Gordon [1 ]
机构
[1] Cleveland Clin, Dept Intervent Radiol, 9500 Euclid Ave, Cleveland, OH 44195 USA
[2] Cleveland Clin, Imaging Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA
[3] Cleveland Clin, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA
[4] KhonKaen Univ, Dept Radiol, Khon Kaen, Thailand
关键词
REGULATORY T-CELLS; GROWTH-HORMONE; HUMAN LIVER; TRANSFORMING GROWTH-FACTOR-BETA-1; MESENCHYMAL TRANSITION; SOMATOSTATIN RECEPTORS; ARTERIAL EMBOLIZATION; BINDING-PROTEINS; PROLIFERATION; CANCER;
D O I
10.1016/j.jvir.2017.03.002
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. HCC develops through a multistep process that involves the local tumor microenvironment, intracellular signaling pathways, and altered metabolic system that allows the cancer proliferation. Understanding the mechanisms of tumor development and progression is critical to developing improved therapies aimed at better survival. This article reviews the molecular mechanisms of HCC development and highlights the potential therapeutic targets for treatments.
引用
收藏
页码:949 / 955
页数:7
相关论文
共 81 条
[1]   Evaluation of 2-deoxy-D-glucose as a chemotherapeutic agent: mechanism of cell death [J].
Aft, RL ;
Zhang, FW ;
Gius, D .
BRITISH JOURNAL OF CANCER, 2002, 87 (07) :805-812
[2]   The intrahepatic biliary epithelium is a target of the growth hormone/insulin-like growth factor 1 axis [J].
Alvaro, D ;
Metalli, VD ;
Alpini, G ;
Onori, P ;
Franchitto, A ;
Barbaro, B ;
Glaser, SS ;
Francis, H ;
Cantafora, A ;
Blotta, I ;
Attili, AF ;
Gaudio, E .
JOURNAL OF HEPATOLOGY, 2005, 43 (05) :875-883
[3]   Oncogenic β-catenin triggers an inflammatory response that determines the aggressiveness of hepatocellular carcinoma in mice [J].
Anson, Marie ;
Crain-Denoyelle, Anne-Marie ;
Baud, Veronique ;
Chereau, Fanny ;
Gougelet, Angelique ;
Terris, Benoit ;
Yamagoe, Satoshi ;
Colnot, Sabine ;
Viguier, Mireille ;
Perret, Christine ;
Couty, Jean-Pierre .
JOURNAL OF CLINICAL INVESTIGATION, 2012, 122 (02) :586-599
[4]   Cellular and molecular mechanisms of hepatocellular carcinoma: an update [J].
Aravalli, Rajagopal N. ;
Cressman, Erik N. K. ;
Steer, Clifford J. .
ARCHIVES OF TOXICOLOGY, 2013, 87 (02) :227-247
[5]   Molecular Mechanisms of Hepatocellular Carcinoma [J].
Aravalli, Rajagopal N. ;
Steer, Clifford J. ;
Cressman, Erik N. K. .
HEPATOLOGY, 2008, 48 (06) :2047-2063
[6]   Mouse models for liver cancer [J].
Bakiri, Latifa ;
Wagner, Erwin F. .
MOLECULAR ONCOLOGY, 2013, 7 (02) :206-223
[7]   Transforming Growth Factor-β1 and CD105 Promote the Migration of Hepatocellular Carcinoma-Derived Endothelium [J].
Benetti, Anna ;
Berenzi, Angiola ;
Gambarotti, Marco ;
Garrafa, Emirena ;
Gelati, Maurizio ;
Dessy, Enrico ;
Portolani, Nazario ;
Piardi, Tullio ;
Giulini, Stefano Maria ;
Caruso, Arnaldo ;
Invernici, Gloria ;
Parati, Eugenio Agostino ;
Nicosia, Roberto ;
Alessandri, Giulio .
CANCER RESEARCH, 2008, 68 (20) :8626-8634
[8]   Laminin-5 stimulates hepatocellular carcinoma growth through a different function of α6β4 and α3β1 integrins [J].
Bergamini, Carlo ;
Sgarra, Concetta ;
Trerotoli, Paolo ;
Lupo, Luigi ;
Azzariti, Amalia ;
Antonaci, Salvatore ;
Giannelli, Gianluigi .
HEPATOLOGY, 2007, 46 (06) :1801-1809
[9]   RETRACTED: Hepatocellular Carcinoma: Novel Molecular Targets in Carcinogenesis for Future Therapies (Retracted Article) [J].
Bertino, Gaetano ;
Demma, Shirin ;
Ardiri, Annalisa ;
Proiti, Maria ;
Gruttadauria, Salvatore ;
Toro, Adriana ;
Malaguarnera, Giulia ;
Bertino, Nicoletta ;
Malaguarnera, Michele ;
Malaguarnera, Mariano ;
Di Carlo, Isidoro .
BIOMED RESEARCH INTERNATIONAL, 2014, 2014
[10]   Differential expression of somatostatin receptor subtypes in hepatocellular carcinomas [J].
Bläker, M ;
Schmitz, M ;
Gocht, A ;
Burghardt, S ;
Schulz, M ;
Bröring, DC ;
Pace, A ;
Greten, H ;
de Weerth, A .
JOURNAL OF HEPATOLOGY, 2004, 41 (01) :112-118